This urgent and important mission has had some amazing mission progress to help those affected by Alzheimer's Disease and related dementias. This is the time of year I ask you to join me with a donation to my walk campaign.
Walk to End Alzheimer's https://t.co/5fzpyCzUv9
The FDA approved a weekly subcutaneous maintenance dosing of Leqembi for early Alzheimer’s. Patients who completed 18 months of IV infusions may now have the option to switch to weekly at-home doses using an autoinjector, which could make treatment less burdensome. https://t.co/i5E1JaVJ1J
On behalf of the over 7 million Americans living with Alzheimer’s, the @alzassociation is calling on Secretary Kennedy to stop spreading harmful Alzheimer’s myths, and preserve the nation’s investment in Alzheimer’s research. Read our statement: https://t.co/BIExGUL42G